The Pharmacology Core currently works with 169 cancer clinical studies representing 5 UCCCC Programs and 16 Disease Programs (leukemia, chest/lung, breast, GU, GI, head/neck, lymphoma, melanoma, transplant, advanced solid tumors, all malignancies, multiple myeloma, OB/GYN, mesothelioma, sarcoma, and cancer risk).

    We are also involved in tissue procurement for the "1200 Patients Project", which studies the implementation of clinical pharmacogenomic testing.